Buy & Sell Amylx Pharmaceuticals Inc (AMLX) – Amylx Pharmaceuticals Inc Price Today
Aura AI Summary
Amylyx Pharmaceuticals (AMLX) stock trades at $18.36, up 3.55% on the day, as investor focus intensifies on the upcoming Phase 3 data readout for its lead drug candidate, avexitide. The company's financials reflect its clinical-stage status with negative profitability metrics (ROE: -61.59% as of latest report), but recent quarterly earnings have shown beats against expectations. A strong analyst consensus, with 10 out of 11 rating it a 'Buy' and a $26.00 price target, underscores high expectations for the pivotal Q3 2026 clinical results.
The investment thesis hinges almost entirely on the success of the avexitide program for post-bariatric hypoglycemia, with a potential 2027 launch. The primary opportunity is significant upside to the consensus target if Phase 3 data are positive. Key risks include clinical trial failure, cash burn from operations ($-123M in 2025), and potential fiduciary concerns highlighted in recent shareholder notices.
Key Stats
- $2.03BMarket Cap
- HealthSector
- -24.59%3M Drawdown
- $1.72BEnterprise Value
- -Dividend Yield
52W Low: $4.23
21 Apr 2025
52W High: $18.36
17 Apr 2026
Amylx Pharmaceuticals Inc (AMLX) is currently valued at a market capitalization of $2.03B, with an enterprise value of $1.72B. Over the past 52 weeks, Amylx Pharmaceuticals Inc has traded between a low of $4.23 and a high of $18.36, highlighting its annual price range. Over the past three months, Amylx Pharmaceuticals Inc has recorded a drawdown of -24.59%, reflecting recent price volatility.
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Technical Indicators
|
|
|
Overall Summary
Bearish (5)Neutral (8)Bullish (10)
News
People also bought
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions